215 related articles for article (PubMed ID: 29523664)
1. Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors.
Zaid MA; Gathirua-Mwangi WG; Fung C; Monahan PO; El-Charif O; Williams AM; Feldman DR; Hamilton RJ; Vaughn DJ; Beard CJ; Cook R; Althouse SK; Ardeshir-Rouhani-Fard S; Dinh PC; Sesso HD; Einhorn LH; Fossa SD; Travis LB;
J Natl Compr Canc Netw; 2018 Mar; 16(3):257-265. PubMed ID: 29523664
[No Abstract] [Full Text] [Related]
2. Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors.
Abu Zaid M; Dinh PC; Monahan PO; Fung C; El-Charif O; Feldman DR; Hamilton RJ; Vaughn DJ; Beard CJ; Cook R; Althouse S; Ardeshir-Rouhani-Fard S; Sesso HD; Huddart R; Mushiroda T; Kubo M; Dolan ME; Einhorn LH; Fossa SD; Travis LB;
J Natl Compr Canc Netw; 2019 May; 17(5):459-468. PubMed ID: 31085753
[TBL] [Abstract][Full Text] [Related]
3. Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.
Boer H; Westerink NL; Altena R; Nuver J; Dijck-Brouwer DAJ; van Faassen M; Klont F; Kema IP; Lefrandt JD; Zwart N; Boezen HM; Smit AJ; Meijer C; Gietema JA
Eur J Cancer; 2016 Feb; 54():104-111. PubMed ID: 26751392
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors.
Willemse PM; Burggraaf J; Hamdy NA; Weijl NI; Vossen CY; van Wulften L; van Steijn-van Tol AQ; Rosendaal FR; Osanto S
Br J Cancer; 2013 Jul; 109(1):60-7. PubMed ID: 23660945
[TBL] [Abstract][Full Text] [Related]
5. Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: A phase 2 randomized controlled trial.
Adams SC; DeLorey DS; Davenport MH; Stickland MK; Fairey AS; North S; Szczotka A; Courneya KS
Cancer; 2017 Oct; 123(20):4057-4065. PubMed ID: 28708930
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Syndrome in Male Survivors of Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Total Body Irradiation, Low-Grade Inflammation, and Hypogonadism.
Muhic E; Mathiesen S; Nielsen MM; Suominen A; Sørensen K; Ifversen M; Nolsöe RL; Pedersen KM; Lähteenmäki P; Nordestgaard BG; Juul A; Jahnukainen K; Müller K
Transplant Cell Ther; 2021 Sep; 27(9):778.e1-778.e8. PubMed ID: 34091072
[TBL] [Abstract][Full Text] [Related]
7. Risk of low bone mineral density in testicular germ cell cancer survivors: association with hypogonadism and treatment modality.
Isaksson S; Bogefors K; Åkesson K; Egund L; Bobjer J; Leijonhufvud I; Giwercman A
Andrology; 2017 Sep; 5(5):898-904. PubMed ID: 28591464
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum-based chemotherapy.
Breekveldt ECH; Ykema BLM; Bisseling TM; Moons LMG; Spaander MCW; Huibregtse IL; van der Biessen-van Beek DTJ; Mulder SF; Saveur L; Kerst JM; Zweers D; Suelmann BBM; de Wit R; Reijm A; van Baalen S; Butterly LF; Hisey WM; Robinson CM; van Vuuren AJ; Carvalho B; Lansdorp-Vogelaar I; Schaapveld M; van Leeuwen FE; Snaebjornsson P; van Leerdam ME
Int J Cancer; 2024 Apr; 154(8):1474-1483. PubMed ID: 38151749
[TBL] [Abstract][Full Text] [Related]
9. Taste and smell function in testicular cancer survivors treated with cisplatin-based chemotherapy in relation to dietary intake, food preference, and body composition.
IJpma I; Renken RJ; Gietema JA; Slart RH; Mensink MG; Lefrandt JD; Ter Horst GJ; Reyners AK
Appetite; 2016 Oct; 105():392-9. PubMed ID: 27298084
[TBL] [Abstract][Full Text] [Related]
10. Leydig cell dysfunction, systemic inflammation and metabolic syndrome in long-term testicular cancer survivors.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Oturai PS; Mortensen J; Hojman P; Helge JW; Daugaard G
Eur J Cancer; 2017 Oct; 84():9-17. PubMed ID: 28772110
[TBL] [Abstract][Full Text] [Related]
11. Nut consumption is associated with decreased health risk factors for cardiovascular disease and metabolic syndrome in U.S. adults: NHANES 1999-2004.
O'Neil CE; Keast DR; Nicklas TA; Fulgoni VL
J Am Coll Nutr; 2011 Dec; 30(6):502-10. PubMed ID: 22331685
[TBL] [Abstract][Full Text] [Related]
12. Reproductive hormones and metabolic syndrome in 24 testicular cancer survivors and their biological brothers.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Oturai PS; Mortensen J; Hojman P; Helge JW; Daugaard G
Andrology; 2017 Jul; 5(4):718-724. PubMed ID: 28598554
[TBL] [Abstract][Full Text] [Related]
13. High risk of hypogonadism in young male cancer survivors.
Isaksson S; Bogefors K; Ståhl O; Eberhard J; Giwercman YL; Leijonhufvud I; Link K; Øra I; Romerius P; Bobjer J; Giwercman A
Clin Endocrinol (Oxf); 2018 Mar; 88(3):432-441. PubMed ID: 29245176
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction.
García-Cruz E; Leibar-Tamayo A; Romero J; Piqueras M; Luque P; Cardeñosa O; Alcaraz A
J Sex Med; 2013 Oct; 10(10):2529-38. PubMed ID: 23898860
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNFalpha treatment: correlation with disease activity.
Papadakis JA; Sidiropoulos PI; Karvounaris SA; Vrentzos GE; Spanakis EK; Ganotakis ES; Kritikos HD; Mikhailidis DP; Boumpas DT
Clin Exp Rheumatol; 2009; 27(2):292-8. PubMed ID: 19473571
[TBL] [Abstract][Full Text] [Related]
16. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk.
Kressel G; Trunz B; Bub A; Hülsmann O; Wolters M; Lichtinghagen R; Stichtenoth DO; Hahn A
Atherosclerosis; 2009 Jan; 202(1):263-71. PubMed ID: 18501910
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of hypogonadism determined by serum free testosterone level in Japanese testicular cancer survivors.
Kurobe M; Kawai K; Suetomi T; Iwamoto T; Waku N; Kawahara T; Kojima T; Joraku A; Miyazaki J; Nishiyama H
Int J Urol; 2018 May; 25(5):457-462. PubMed ID: 29478250
[TBL] [Abstract][Full Text] [Related]
18. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
[TBL] [Abstract][Full Text] [Related]
19. Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors.
Ekedahl H; Isaksson S; Ståhl O; Bogefors K; Romerius P; Eberhard J; Giwercman A
BMC Cancer; 2022 Feb; 22(1):157. PubMed ID: 35135482
[TBL] [Abstract][Full Text] [Related]
20. What is the damage? Testicular germ cell tumour survivors deficient in testosterone at risk of metabolic syndrome and a need for medical intervention.
Poniatowska G; Michalski W; Kucharz J; Jonska-Gmyrek J; Wieszczy P; Nietupski K; Demkow T; Dedecjus M; Sadowska M; Kalinowski T; Grochulska-Nalazek B; Nowatorska A; Stelmasiak P; Wiechno PJ
Med Oncol; 2020 Aug; 37(9):82. PubMed ID: 32767179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
